Drug factory · FDA FEI 3011566408

LSNE-LEON SLU, D/B/A: PCI Pharma Services

CALLE NICOSTRATO VELA, PQ. TECNOLOGICO LEÓN), S/N, M1.1-M1.2, Leon, Spain

Spain: 1

Problems found, fixed voluntarily at FDA's last inspection, Mar 21, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

2 drug inspections on record since 2021: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
TestosteroneMakes it and tests it Cipla USA., Inc. 69097-536, 69097-537

FDA inspection history

EndedResultProgramProblems noted
Mar 21, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
May 28, 2021Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; manufacture; pack.